[ad_1] Shots: Royal Philips has launched Verida, a detector-based spectral CT fully powered by AI, at RSNA 2025, with availability in select markets beginning in 2026 Verida integrates AI across the entire imaging chain to deliver high-quality spectral & high-definition images with minimal noise, while enabling significant dose reductions & reducing energy use by ~45% Verida…
[ad_1] Check out our top posts for the past month. Posts are listed by the number of page views they attracted during the month, most popular first. Twelve Songs That Remind Me What Caring Is All About The Box on the Shelf: A Strategy for Handling Difficult Issues and Situations One Must Imagine Sisyphus Happy:…
[ad_1] Wockhardt New Drug Application for Breakthrough antibiotic Zaynich accepted by USFDA We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Holiday cheer is great. Holiday skin? Not always. One weekend of salty snacks, sugary treats, late nights, cold air, travel, and—you guessed it—stress—and suddenly you’re dealing with dry skin, dull skin, stress acne, irritation, or a cranky, damaged skin barrier. Sensitive skin especially tends to tap out this time of year. Everybody has a…
[ad_1] Gastroenterologist attacked inside OPD at Barmer Hospital, suffers fractures We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] West Pharmaceutical Services has long been a reference point in primary packaging for injectable therapies. Its latest launch—the West Synchrony™ prefillable syringe (PFS) system—has won the Product Launches award in the Prefillable Syringe Systems category in the 2025 Pharmaceutical Technology Excellence Awards. West Pharmaceutical Services won the award for introducing an integrated, data-driven syringe…
[ad_1] Ganesh Baraiya, 3-feet-tall doctor, secures first medical officer appointment after legal battle We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Drug maker Lupin on Monday said it has received approval from the US health regulator for a biosimilar indicated for the treatment of neutropenia in cancer patients. The US Food and Drug Administration (USFDA) has approved Armlupeg (pegfilgrastim-unne) 6 mg/0.6 mL injection for subcutaneous use in a single-dose prefilled syringe, as biosimilar to Neulasta…
[ad_1] Theia Ventures, an India – based specialist early-stage fund focused on AI, deeptech, energy transition, and decarbonisation, has announced that it has led a pre-seed investment in Lemnisca, a Bio-AI company; building intelligent systems to scale biomanufacturing. This round also saw participation from PointOne Capital and Dr Satakarni Makkapati. This fund will support Lemnisca’s…
[ad_1] Shots: Ascletis Pharma has selected ASC37 tablets (PO), a GLP-1R/GIPR/GCGR triple peptide agonist, as a clinical development candidate ASC37, utilizing Ascletis’ POTENT tech, showed an average of 4.2% absolute oral bioavailability, higher than semaglutide, tirzepatide, & retatrutide in oral SNAC formulations, & ~57-fold greater AUC vs retatrutide (PO) in NHP studies, with an observed…